Vycor Medical (VYCO) Total Current Liabilities (2010 - 2026)
Vycor Medical's (VYCO) quarterly Total Current Liabilities came in at $4.9 million in Q2 2026, up 7.61% year-over-year from $4.6 million in Q2 2025, and little changed quarter-over-quarter from $4.9 million in Q1 2026.
Analysis
Vycor Medical (VYCO) Total Current Liabilities (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Total Current Liabilities for 17 consecutive years, with $4.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Current Liabilities rose 7.61% year-over-year to $4.9 million in Q2 2026; TTM through Jun 2026 was $4.9 million, a 7.61% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 6.34% from the prior year.
- Total Current Liabilities was $4.9 million for Q2 2026 at Vycor Medical, roughly flat from $4.9 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $4.9 million in Q1 2026 and troughed at $3.4 million in Q1 2022.
- A 5-year average of $4.2 million and a median of $4.3 million in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities climbed 16.58% in 2022 and increased 5.76% in 2025, its largest moves.
- Over 5 years, Total Current Liabilities stood at $3.7 million in 2022, then rose by 11.48% to $4.1 million in 2023, then rose by 10.36% to $4.5 million in 2024, then grew by 6.34% to $4.8 million in 2025, then grew by 3.12% to $4.9 million in 2026.
- The last three Total Current Liabilities figures came in at $4.9 million (Q2 2026), $4.9 million (Q1 2026), and $4.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | 4.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.93 Mn |
| Mar 31, 2026 | 4.95 Mn |
| Dec 31, 2025 | 4.78 Mn |
| Sep 30, 2025 | 4.82 Mn |
| Jun 30, 2025 | 4.58 Mn |
| Mar 31, 2025 | 4.65 Mn |
| Dec 31, 2024 | 4.50 Mn |
| Sep 30, 2024 | 4.55 Mn |
| Jun 30, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Dec 31, 2023 | 4.07 Mn |
| Sep 30, 2023 | 4.03 Mn |
| Jun 30, 2023 | 3.78 Mn |
| Mar 31, 2023 | 3.79 Mn |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 3.62 Mn |
| Jun 30, 2022 | 3.36 Mn |
| Mar 31, 2022 | 3.35 Mn |
| Dec 31, 2021 | 3.15 Mn |
| Sep 30, 2021 | 3.11 Mn |